Effects of a Novel Glucokinase Activator, Dorzagliatin, on Glycemic Control and Glucose Fluctuation in Drug-Na ïve Patients with Type 2 Diabetes Mellitus

CONCLUSIONS: This study suggests that dorzagliatin therapy could effectively improve glycemic control and glucose fluctuation in drug-naïve patients with T2DM.PMID:38179187 | PMC:PMC10764651 | DOI:10.1155/2023/4996057

Source: International Journal of Endocrinology - January 5, 2024 Category: Endocrinology Authors: Yuming Wang Xiaofei Su Wenli Zhang Yunting Zhou Xiao Zhou Wei Yang Huiqin Li Jianhua Ma Source Type: research